Table 2 Demographics and comorbidities of cohort
N = 116 (out of 118 swabs) | |
|---|---|
Demographics | N (proportion) |
Age (mean ± SE) | 60.0±1.37 |
Female | 52 (0.45) |
Non-white race | 17 (0.15) |
Comorbidities | |
C. difficile infection | 15 (0.13) |
Leukemia | 30 (0.26) |
Lymphoma | 14 (0.12) |
Bone marrow transplant | 20 (0.17) |
Solid organ malignancy | 81 (0.70) |
Metastatic malignancy | 54 (0.47) |
Diabetes | 47 (0.41) |
Coronary artery disease | 18 (0.16) |
Congestive heart failure | 38 (0.33) |
COPD | 53 (0.46) |
Peripheral vascular disease | 7 (0.06) |
End stage renal disease | 46 (0.40) |
Connective tissue disease | 5 (0.040) |
Peptic ulcer disease | 16 (0.14) |
Cirrhosis | 12 (0.10) |
Cerebrovascular disease | 24 (0.21) |
Hemiplegia | 10 (0.10) |
Dementia | 4 (0.03) |
Charlson Score (mean ± SE) | 4.0 ± 0.19 |
Admission diagnosis | |
Cardiopulmonary disorder | 22 (0.19) |
Gastrointestinal disorder | 12 (0.1) |
Complications of chemotherapy | 36 (0.31) |
Neurologic abnormality | 3 (0.02) |
Sepsis syndrome | 34 (0.29) |
Non-infectious transplant complication | 4 (0.03) |
Trauma | 5 (0.04) |